The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Medicare/Medicaid

Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to payment for prescription drugs. Issues concerning drug shortages. Issues related to extension of the hospital at home program and H.R. 7148 (P.L. 119-75), Consolidated Appropriations Act of 2026. Issues related to the Medicare Advantage star rating eye exam quality measure.

Taxation/Internal Revenue Code

Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes. Monitor issues related to OECD Pillar 2.

Health Issues

Monitored issues related to pharmaceutical prices. Issues regarding the pharmaceutical and medical device supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning emergency preparedness and critical medical supplies. Issues concerning regulatory reforms.

Trade (domestic/foreign)

Issues related to tariffs.

Bills named in this filing 3

H.R. 5376
Impacts and Outcomes for Health Career Training Act
H.R. 7148
Consolidated Appropriations Act, 2026
H.R. 1
One Big Beautiful Bill Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.